Log in

NASDAQ:RELV - Reliv International Stock Price, Forecast & News

-0.04 (-0.99 %)
(As of 12/13/2019 04:00 PM ET)
Today's Range
Now: $3.99
50-Day Range
MA: $4.20
52-Week Range
Now: $3.99
Volume1,195 shs
Average Volume3,996 shs
Market Capitalization$6.98 million
P/E RatioN/A
Dividend YieldN/A
Reliv' International, Inc. develops, manufactures, and markets nutritional supplements that address basic nutrition, wellness needs, weight management, and sports nutrition. Its nutritional supplements primarily include Reliv Classic and Reliv NOW, which are basic nutritional supplements containing a balanced blend of vitamins, minerals, proteins, and herbs; Innergize!, an isotonic sports supplement in two flavors; FibRestore, a high-fiber and antioxidant supplement; and LunaRich X, a soy concentrate with elevated levels of lunasin in capsule form. The company markets and sells its products through a network of distributors in the United States, Australia, Austria, Canada, France, Germany, Indonesia, Ireland, Malaysia, Mexico, the Netherlands, New Zealand, the Philippines, Singapore, and the United Kingdom. Reliv' International, Inc. was founded in 1984 and is headquartered in Chesterfield, Missouri.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
SectorConsumer Staples
Current SymbolNASDAQ:RELV



Sales & Book Value

Annual Sales$36.12 million
Book Value$6.50 per share


Net Income$-1,900,000.00


Market Cap$6.98 million
Next Earnings Date4/3/2020 (Estimated)
OptionableNot Optionable

Receive RELV News and Ratings via Email

Sign-up to receive the latest news and ratings for RELV and its competitors with MarketBeat's FREE daily newsletter.

Reliv International (NASDAQ:RELV) Frequently Asked Questions

What is Reliv International's stock symbol?

Reliv International trades on the NASDAQ under the ticker symbol "RELV."

How were Reliv International's earnings last quarter?

Reliv International, Inc (NASDAQ:RELV) announced its quarterly earnings data on Friday, August, 9th. The company reported ($0.22) earnings per share for the quarter. The company had revenue of $8.26 million for the quarter. Reliv International had a negative return on equity of 0.63% and a negative net margin of 0.21%. View Reliv International's Earnings History.

When is Reliv International's next earnings date?

Reliv International is scheduled to release their next quarterly earnings announcement on Friday, April 3rd 2020. View Earnings Estimates for Reliv International.

Has Reliv International been receiving favorable news coverage?

News coverage about RELV stock has been trending somewhat negative recently, according to InfoTrie Sentiment. The research group identifies positive and negative media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Reliv International earned a news sentiment score of -1.8 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the next several days. View News Stories for Reliv International.

Are investors shorting Reliv International?

Reliv International saw a increase in short interest during the month of November. As of November 29th, there was short interest totalling 6,400 shares, an increase of 73.0% from the November 14th total of 3,700 shares. Based on an average trading volume of 2,800 shares, the days-to-cover ratio is currently 2.3 days. Approximately 0.5% of the company's shares are sold short. View Reliv International's Current Options Chain.

Who are some of Reliv International's key competitors?

What other stocks do shareholders of Reliv International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Reliv International investors own include NovaBay Pharmaceuticals (NBY), RadNet (RDNT), VIVUS (VVUS), Rite Aid (RAD), Scisys Group (SSY), Acer Therapeutics (ACER), Catalyst Biosciences (CBIO), Cerus (CERS), Celsion (CLSN) and Conatus Pharmaceuticals (CNAT).

Who are Reliv International's key executives?

Reliv International's management team includes the folowing people:
  • Mr. Robert L. Montgomery, Co-Founder & Chairman (Age 77)
  • Dr. Carl W. Hastings, Vice Chairman, Chief Scientific Officer & Member of the Scientific Advisory Board (Age 77)
  • Mr. Thomas W. Pinnock III, Pres of Sales & Marketing (Age 68)
  • Mr. Ryan A. Montgomery, CEO, Pres & Director (Age 45)
  • Mr. Steven D. Albright CPA, Sr. VP & CFO (Age 57)

How do I buy shares of Reliv International?

Shares of RELV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Reliv International's stock price today?

One share of RELV stock can currently be purchased for approximately $3.99.

How big of a company is Reliv International?

Reliv International has a market capitalization of $6.98 million and generates $36.12 million in revenue each year. Reliv International employs 156 workers across the globe.View Additional Information About Reliv International.

What is Reliv International's official website?

The official website for Reliv International is http://www.reliv.com/.

How can I contact Reliv International?

Reliv International's mailing address is 136 CHESTERFIELD INDUSTRIAL BLVD, CHESTERFIELD MO, 63005. The company can be reached via phone at 636-537-9715 or via email at [email protected]

MarketBeat Community Rating for Reliv International (NASDAQ RELV)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  97 (Vote Outperform)
Underperform Votes:  81 (Vote Underperform)
Total Votes:  178
MarketBeat's community ratings are surveys of what our community members think about Reliv International and other stocks. Vote "Outperform" if you believe RELV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RELV will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/14/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel